Cargando…

Reprogramming Urine‐Derived Cells using Commercially Available Self‐Replicative RNA and a Single Electroporation

We describe a protocol for efficient generation of human‐induced pluripotent stem cells (hiPSCs) from urine‐derived cells (UDCs) obtained from adult donors using self‐replicative RNA containing the reprogramming factors OCT3/4, SOX2, KLF4, GLIS1, and c‐MYC (ReproRNA‐OKSGM). After electroporation, tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Bouma, Marga J., Arendzen, Christiaan H., Mummery, Christine L., Mikkers, Harald, Freund, Christian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7540473/
https://www.ncbi.nlm.nih.gov/pubmed/32956580
http://dx.doi.org/10.1002/cpsc.124
_version_ 1783591216596647936
author Bouma, Marga J.
Arendzen, Christiaan H.
Mummery, Christine L.
Mikkers, Harald
Freund, Christian
author_facet Bouma, Marga J.
Arendzen, Christiaan H.
Mummery, Christine L.
Mikkers, Harald
Freund, Christian
author_sort Bouma, Marga J.
collection PubMed
description We describe a protocol for efficient generation of human‐induced pluripotent stem cells (hiPSCs) from urine‐derived cells (UDCs) obtained from adult donors using self‐replicative RNA containing the reprogramming factors OCT3/4, SOX2, KLF4, GLIS1, and c‐MYC (ReproRNA‐OKSGM). After electroporation, transfection efficiency is quantified by measuring OCT3/4‐expressing UDCs using flow cytometry and should be ≥0.1%. hiPSC colonies emerge within 3 weeks after transfection and express multiple pluripotency markers. Moreover, the UDC‐derived hiPSCs are able to differentiate into cells of all three germ layers and display normal karyotypes. ReproRNA‐OKSGM is available commercially and only requires a single transfection step so that the protocol is readily accessible, as well as straightforward. In addition to a detailed step‐by‐step description for generating clonal hiPSCs from UDCs using ReproRNA‐OKSGM, we provide guidance for basic pluripotency characterization of the hiPSC lines. © 2020 The Authors. Basic Protocol: Reprogramming of urine‐derived cells using ReproRNA‐OKSGM Support Protocol 1: Determination of the pluripotency status of hiPSCs by flow cytometry Support Protocol 2: Characterization of functional pluripotency of hiPSCs
format Online
Article
Text
id pubmed-7540473
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-75404732020-10-09 Reprogramming Urine‐Derived Cells using Commercially Available Self‐Replicative RNA and a Single Electroporation Bouma, Marga J. Arendzen, Christiaan H. Mummery, Christine L. Mikkers, Harald Freund, Christian Curr Protoc Stem Cell Biol Protocol We describe a protocol for efficient generation of human‐induced pluripotent stem cells (hiPSCs) from urine‐derived cells (UDCs) obtained from adult donors using self‐replicative RNA containing the reprogramming factors OCT3/4, SOX2, KLF4, GLIS1, and c‐MYC (ReproRNA‐OKSGM). After electroporation, transfection efficiency is quantified by measuring OCT3/4‐expressing UDCs using flow cytometry and should be ≥0.1%. hiPSC colonies emerge within 3 weeks after transfection and express multiple pluripotency markers. Moreover, the UDC‐derived hiPSCs are able to differentiate into cells of all three germ layers and display normal karyotypes. ReproRNA‐OKSGM is available commercially and only requires a single transfection step so that the protocol is readily accessible, as well as straightforward. In addition to a detailed step‐by‐step description for generating clonal hiPSCs from UDCs using ReproRNA‐OKSGM, we provide guidance for basic pluripotency characterization of the hiPSC lines. © 2020 The Authors. Basic Protocol: Reprogramming of urine‐derived cells using ReproRNA‐OKSGM Support Protocol 1: Determination of the pluripotency status of hiPSCs by flow cytometry Support Protocol 2: Characterization of functional pluripotency of hiPSCs John Wiley and Sons Inc. 2020-09-21 2020-12 /pmc/articles/PMC7540473/ /pubmed/32956580 http://dx.doi.org/10.1002/cpsc.124 Text en © 2020 The Authors. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Protocol
Bouma, Marga J.
Arendzen, Christiaan H.
Mummery, Christine L.
Mikkers, Harald
Freund, Christian
Reprogramming Urine‐Derived Cells using Commercially Available Self‐Replicative RNA and a Single Electroporation
title Reprogramming Urine‐Derived Cells using Commercially Available Self‐Replicative RNA and a Single Electroporation
title_full Reprogramming Urine‐Derived Cells using Commercially Available Self‐Replicative RNA and a Single Electroporation
title_fullStr Reprogramming Urine‐Derived Cells using Commercially Available Self‐Replicative RNA and a Single Electroporation
title_full_unstemmed Reprogramming Urine‐Derived Cells using Commercially Available Self‐Replicative RNA and a Single Electroporation
title_short Reprogramming Urine‐Derived Cells using Commercially Available Self‐Replicative RNA and a Single Electroporation
title_sort reprogramming urine‐derived cells using commercially available self‐replicative rna and a single electroporation
topic Protocol
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7540473/
https://www.ncbi.nlm.nih.gov/pubmed/32956580
http://dx.doi.org/10.1002/cpsc.124
work_keys_str_mv AT boumamargaj reprogrammingurinederivedcellsusingcommerciallyavailableselfreplicativernaandasingleelectroporation
AT arendzenchristiaanh reprogrammingurinederivedcellsusingcommerciallyavailableselfreplicativernaandasingleelectroporation
AT mummerychristinel reprogrammingurinederivedcellsusingcommerciallyavailableselfreplicativernaandasingleelectroporation
AT mikkersharald reprogrammingurinederivedcellsusingcommerciallyavailableselfreplicativernaandasingleelectroporation
AT freundchristian reprogrammingurinederivedcellsusingcommerciallyavailableselfreplicativernaandasingleelectroporation